B. Metzler seel. Sohn & Co. AG Makes New Investment in Agilent Technologies, Inc. $A

Key Points

• B. Metzler seel. Sohn & Co. AG purchased 16,309 Agilent Technologies shares in the second quarter, valued at approximately $2.17 million. Several smaller institutional investors also opened new positions.
• Agilent exceeded quarterly expectations, reporting $1.49 in EPS versus the $1.41 consensus and $1.83 billion in revenue, up 10% year over year. The company guided to fiscal 2026 EPS of $6.00–$6.10.
• Analyst sentiment remains positive, with the stock holding a consensus “Moderate Buy” rating and an average price target of $160.24, near its reported $159.25 share price.

B. Metzler seel. Sohn & Co. AG purchased a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 16,309 shares of the medical research company's stock, valued at approximately $2,166,000.

Several other institutional investors have also modified their holdings of A. SHP Wealth Management acquired a new stake in Agilent Technologies in the 4th quarter valued at about $26,000. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $28,000. Finally, Entrust Financial LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $31,000.

Agilent Technologies Price Performance

A stock opened at $159.25 on Friday. The business has a 50 day moving average price of $137.57 and a 200 day moving average price of $126.23. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $44.98 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 2.81 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.51.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the firm posted $1.31 earnings per share. The firm's revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Wednesday, June 3rd. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, May 28th. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective for the company. Robert W. Baird lifted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 26th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Sunday, August 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source